
H. C. Wainwright & Co.
North America, New York, United States, New York
Description
H.C. Wainwright & Co. blends traditional values with innovative services, operating with integrity and offering leading-edge investment.
Investor Profile
H. C. Wainwright & Co. has made 2 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United States (50%)
- Israel (50%)
Industry Focus
- Biotechnology
- Health Care
- Genetics
- Manufacturing
- Medical Device
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.